![John Beaton](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Beaton
Keine laufenden Positionen mehr
Profil
Mr. John Beaton is a partner at Discovery Investment Fund Ltd.
in the United Kingdom.
He was the founder of Kolfor Plant Ltd, which became a major supplier of plant services to the North Sea Oil & Gas Industry and worldwide.
He was Chairman and Managing Director of Kolfor Plant for 31 years up to when the company was acquired by Atlas Copco Sweden in 2004.
Since then he has actively invested in several new companies including Dundee Cell Products Ltd, of which he joined the board in 2007.
.
Mr. Beaton also obtained an award of MBE (Member of the British Empire).
He is an Honorary Fellow of the University of Abertay and was the recipient of the UK Offshore Lifetime Achievement Award in 2000.
Ehemalige bekannte Positionen von John Beaton
Unternehmen | Position | Ende |
---|---|---|
DC Biosciences Ltd.
![]() DC Biosciences Ltd. BiotechnologyHealth Technology DC Biosciences Ltd. provides bioreagents and life science services. The firm’s products include cell extracts, fresh primary mammalian cells, recombinant proteins, steroid beads, fluorescent cell markers, and SILAC reagents. Its services include custom antibody service, custom antibody service, DNA cloning services, gene synthesis service, and protein expression, gene to stable cell line, mass spectrometry, quantitative proteomics, and peptide synthesis. The company was founded by Angus Lamond and Paul Ajuh in June 2006 and is headquartered in Dundee, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
DC Biosciences Ltd.
![]() DC Biosciences Ltd. BiotechnologyHealth Technology DC Biosciences Ltd. provides bioreagents and life science services. The firm’s products include cell extracts, fresh primary mammalian cells, recombinant proteins, steroid beads, fluorescent cell markers, and SILAC reagents. Its services include custom antibody service, custom antibody service, DNA cloning services, gene synthesis service, and protein expression, gene to stable cell line, mass spectrometry, quantitative proteomics, and peptide synthesis. The company was founded by Angus Lamond and Paul Ajuh in June 2006 and is headquartered in Dundee, the United Kingdom. | Health Technology |